CJC-1295 (No DAC)
Lyophilized synthetic peptide reference material. Characterized by HPLC and MS. For in-vitro laboratory research use only. Not for human or veterinary use.
Sold strictly as a lyophilized analytical reference standard for in-vitro laboratory research by qualified professionals. Not for use in any living organism. Not a drug, food, cosmetic, or dietary supplement. No medical, therapeutic, diagnostic, or health claims are made. No dosing or administration guidance is provided.
Research Overview
A short-acting GHRH fragment — often paired with Ipamorelin in the literature.
CJC-1295 (No DAC), also called modified GRF (1-29), is a shortened lab-made version of growth hormone-releasing hormone. Without the DAC modification it clears quickly, producing short, pulse-like signaling that researchers have used to model natural release rhythms.
- Pulse-like GHRH receptor signaling
- How quickly it clears versus the DAC version
- Pairings with Ipamorelin in cell models
- Growth hormone release patterns
The information above is provided for educational and research reference purposes only. These products are intended for laboratory research use only and are not approved for human consumption. Statements on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Certificate of Analysis
Every batch of CJC-1295 (No DAC) is independently characterized by HPLC and mass spectrometry. The full COA — including chromatogram, mass spec data, net purity, and net content verification — is available on request for the lot you receive.
- Compound
- CJC-1295 (No DAC)
- CAS
- 863288-34-0
- Method
- HPLC + MS
- Purity
- >99.0% (HPLC)
- Grade
- Research
- Net Content
- 10 mg / vial
